A double-blind, placebo-controlled, multicentre study to evaluate dirucotide in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Selmaj, K.
Verco, T.
Ossanna, M.
Nilsson, M.
Ferenczi, L.
Chappell, A.
Arfors, L.
机构：
[1] Med Univ Lodz, Lodz, Poland
[2] BioMS Med Corp, Edmonton, AB, Canada
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
MULTIPLE SCLEROSIS | 2009年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [1] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    [J]. JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [2] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    [J]. PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [3] Efficacy and Safety of Tabalumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
    Silk, Maria
    Nantz, Eric
    [J]. NEUROLOGY, 2018, 90
  • [4] Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
    Kappos, Ludwig
    Gold, Ralf
    Miller, David H.
    MacManus, David G.
    Havrdova, Eva
    Limmroth, Volker
    Polman, Chris H.
    Schmierer, Klaus
    Yousry, Tarek A.
    Yang, Minhua
    Eraksoy, Mefkure
    Meluzinova, Eva
    Rektor, Ivan
    Dawson, Katherine T.
    Sandrock, Alfred W.
    O'Neill, Gilmore N.
    [J]. LANCET, 2008, 372 (9648): : 1463 - 1472
  • [5] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    [J]. FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [6] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
    Ebers, GC
    Rice, G
    Lesaux, J
    Paty, D
    Oger, J
    Li, DKB
    Beall, S
    Devonshire, V
    Hashimoto, S
    Hooge, J
    Kastrukoff, L
    Krieger, C
    Mezei, M
    Seland, P
    Vorobeychi, G
    Morrison, W
    Nelson, J
    Freedman, MS
    Chrisie, S
    Nelson, R
    Rabinovitch, H
    Freedman, C
    Hartung, HP
    Rieckmann, P
    Archelos, J
    Jung, S
    Weilbach, F
    Flachenecke, P
    Sauer, J
    Hommes, O
    Jongen, P
    Brouwer, S
    McLeod, J
    Pollard, J
    Ng, R
    Sandberg-Wollheim, M
    Källén, K
    Nilsson, P
    Ekberg, R
    Lundgren, A
    Jadbäck, G
    Wikström, J
    Multanen, J
    Valjakka, M
    Carton, H
    Lissoir, F
    Declerq, I
    Vieren, M
    Peeters, E
    Dubois, B
    [J]. LANCET, 1998, 352 (9139): : 1498 - 1504
  • [7] A placebo-controlled, randomized, double-blind, MRI trial of antiherpes therapy in patients with relapsing-remitting multiple sclerosis (RRMS)
    Jakobsen, J
    Bech, E
    Gadeberg, P
    Hansen, HJ
    Christensen, T
    Haahr, S
    Hollsberg, P
    Lycke, J
    Malmestrom, C
    Ekholm, S
    Bergstrom, T
    Svennerholm, B
    Andersen, O
    [J]. NEUROLOGY, 2001, 56 (08) : A74 - A74
  • [8] A double-blind, randomized, versus-placebo study of palmitoylethanolamide in relapsing-remitting multiple sclerosis
    Orefice, N.
    Calabrese, M.
    Carotenuto, A.
    Cerillo, I.
    Montella, S.
    Cerullo, G.
    Marsili, A.
    Lanzillo, R.
    Sacca, F.
    Morra, V. Brescia
    Calignano, A.
    Orefice, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 114 - 115
  • [9] A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of daclizumab HYP monotherapy in relapsing-remitting multiple sclerosis: primary results of the SELECT trial
    Giovannoni, G.
    Gold, R.
    Selmaj, K.
    Havrdova, E.
    Montalban, X.
    Radue, E. W.
    Stefoski, D.
    Robinson, R.
    Riester, K.
    Elkins, J.
    O'Neill, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S508 - S509
  • [10] A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Safety and Efficacy of Daclizumab HYP Monotherapy in Relapsing-Remitting Multiple Sclerosis: Primary Results of the SELECT Trial
    Gold, Ralf
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Havrdova, Eva
    Montalban, Xavier
    Radue, Ernst-Wilhelm
    Stefoski, Dusan
    Robinson, Randy
    Riester, Katherine
    Elkins, Jacob
    O'Neill, Gilmore
    [J]. NEUROLOGY, 2012, 78
12345